Ann: US Patent Office to allow key patent for Progenza, page-25

Those are all excellent points Biotechasx, particularly those you make about stem cell secretions.

The potential for topical application of Sygenus gel to be further validated as a pain relief alternative to morphine is also an interesting one in these times of rampant and escalating opioid addiction. You only have to look at the market growth in MVP's Penthrox inhaler (the green whistle) for achieving non-opioid pain relief to recognise that effective alternatives to opioid analgesics are highly valued in the management of pain.

zeno9